Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
SMSaude
1 other identifier
interventional
1,352
1 country
1
Brief Summary
Mobile phone SMS are increasingly used to promote positive health behaviour with an aim to improve health outcomes. However, robust data on the efficacy of SMS on health seeking behaviour and patient outcomes in resource-limited settings is sparse. The SMSaude study aims to assess whether regular SMS-reminders improve retention on antiretroviral therapy (ART) and prevention of mother to child transmission of HIV (PMTCT) programmes in Mozambique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 25, 2013
CompletedFirst Posted
Study publicly available on registry
July 29, 2013
CompletedJuly 29, 2013
July 1, 2013
1.5 years
July 25, 2013
July 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention in ART care
12 months
Secondary Outcomes (1)
Retention in PMTCT care
until 8 weeks post partum
Study Arms (4)
ART no SMS reminders
ACTIVE COMPARATORcontrol group
PMTCT no SMS reminders
ACTIVE COMPARATORcontrol group
SMS reminders to PMTCT cohort
EXPERIMENTALexperimental group
SMS reminders to ART cohort
EXPERIMENTALexperimental group
Interventions
Intervention participants only will be sent text messages to their phones. The content of text messages will have a maximum of 160 characters and not mention HIV and will state the dates for the forthcoming consultations, visits to the pharmacy, lab results, time to take medication and reminders for patients who miss appointments.
Eligibility Criteria
You may qualify if:
- On ART for \>15 days (for ART only)
- Live in province and plan to stay for 12+ months
- Have cell phone
- Literate
- For PMTCT (in addition to above criteria):
- \- pregnant between 8-28 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Absolute Return for Kidslead
- Vodacomcollaborator
- United States Agency for International Development (USAID)collaborator
- Department for International Development, United Kingdomcollaborator
Study Sites (1)
6 Health Facilities
Matola, Xinavane, Machava and Namaacha, Maputo, Mozambique
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cesar de Palha, MD
University of Eduardo Mondlane
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2013
First Posted
July 29, 2013
Study Start
November 1, 2011
Primary Completion
May 1, 2013
Study Completion
June 1, 2013
Last Updated
July 29, 2013
Record last verified: 2013-07